| P50 | author | Mishka Terplan | Q65093825 |
| | Nyaradzo Longinaker | Q65093826 |
| P2093 | author name string | Caitlin E Martin | |
| P2860 | cites work | Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence | Q24239965 |
| | Demographic and substance abuse trends among pregnant and non-pregnant women: eleven years of treatment admission data | Q33993064 |
| | Neonatal drug withdrawal | Q34250791 |
| | Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. | Q34271907 |
| | Prenatal substance abuse: short- and long-term effects on the exposed fetus | Q34329692 |
| | Prescription Drug Abuse & Diversion: Role of the Pain Clinic | Q34537419 |
| | Prevalence of hospitalized live births affected by alcohol and drugs and parturient women diagnosed with substance abuse at liveborn delivery: United States, 1999-2008 | Q35906362 |
| | Geographic variation in opioid prescribing in the U.S. | Q36430979 |
| | Methadone and buprenorphine for the management of opioid dependence in pregnancy | Q38003398 |
| | Prevalence of prescription and illicit drugs in pregnancy-associated non-natural deaths of Florida mothers, 1999-2005. | Q38123524 |
| | Medication-assisted treatment with methadone: assessing the evidence | Q38163891 |
| | Universal screening for substance abuse at the time of parturition | Q39834868 |
| | Current trends in narcotic use in pregnancy and neonatal outcomes | Q43500305 |
| | Trends in injection drug use among pregnant women admitted into drug treatment: 1994-2006. | Q43835055 |
| | Vital signs: overdoses of prescription opioid pain relievers---United States, 1999--2008. | Q44331377 |
| | ACOG Committee Opinion No. 524: Opioid abuse, dependence, and addiction in pregnancy | Q44334012 |
| | Lessons learned from a comparison of evidence-based research in pregnant opioid-dependent women | Q44336832 |
| | Vital signs: overdoses of prescription opioid pain relievers and other drugs among women--United States, 1999-2010. | Q44340140 |
| | Methadone maintenance vs. methadone taper during pregnancy: maternal and neonatal outcomes | Q44756475 |
| | Substance use among women: associations with pregnancy, parenting, and race/ethnicity | Q44877567 |
| | Methamphetamine use among pregnant women. | Q46001466 |
| | Results of 313 consecutive live births of infants delivered to patients in the New York City Methadone Maintenance Treatment Program | Q46390772 |
| | Maternal drug use and its effect on neonates: a population-based study in Washington State | Q47866950 |
| | Prevention and treatment issues for pregnant cocaine-dependent women and their infants. | Q51510045 |
| | Estimating the costs of substance abuse to the Medicaid hospital care program. | Q52271967 |
| P433 | issue | 1 | |
| P921 | main subject | opioid | Q427523 |
| | opioid use disorder | Q1639178 |
| P304 | page(s) | 37-42 | |
| P577 | publication date | 2014-07-23 | |
| P1433 | published in | Journal of Substance Abuse Treatment | Q15762042 |
| P1476 | title | Recent trends in treatment admissions for prescription opioid abuse during pregnancy | |
| P478 | volume | 48 | |